Sernova Biotherapeutics (SEOVF) Expected to Announce Quarterly Earnings on Thursday

Sernova Biotherapeutics (OTCMKTS:SEOVF) is expected to announce its resultson Thursday, March 19th. Analysts expect the company to announce earnings of ($0.0073) per share for the quarter.

Sernova Biotherapeutics (OTCMKTS:SEOVF) last issued its quarterly earnings results on Friday, December 19th. The company reported ($0.01) earnings per share (EPS) for the quarter.

Sernova Biotherapeutics Stock Down 3.6%

Shares of SEOVF stock opened at $0.12 on Thursday. The stock has a 50-day moving average price of $0.11 and a 200 day moving average price of $0.11. The firm has a market cap of $42.02 million, a price-to-earnings ratio of -3.12 and a beta of 0.98. Sernova Biotherapeutics has a 12 month low of $0.09 and a 12 month high of $0.17.

Sernova Biotherapeutics Company Profile

Sernova Biotherapeutics is a clinical‐stage biotechnology company focused on developing and commercializing cell‐based therapeutic technologies for patients with chronic and life‐threatening diseases. Headquartered in London, Ontario, Canada, the firm is advancing an implantable device platform designed to support the long-term survival and function of therapeutic cells. The company’s lead product candidate, known as the Cell Pouch System, is engineered to create a vascularized environment in which transplanted cells can thrive, with an initial emphasis on treating patients with type 1 diabetes.

In its core program, Sernova has initiated a Phase I/II clinical trial evaluating the safety and efficacy of the Cell Pouch System in individuals with type 1 diabetes who require islet cell transplantation.